Bausch Health Companies Inc.
BHC.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.92B | 9.74B | 9.62B | 9.52B | 9.37B |
| Total Other Revenue | 113.00M | 117.00M | 115.00M | 107.00M | 102.00M |
| Total Revenue | 10.03B | 9.86B | 9.73B | 9.63B | 9.47B |
| Cost of Revenue | 2.94B | 2.89B | 2.84B | 2.78B | 2.76B |
| Gross Profit | 7.09B | 6.97B | 6.89B | 6.84B | 6.71B |
| SG&A Expenses | 3.37B | 3.42B | 3.36B | 3.29B | 3.23B |
| Depreciation & Amortization | 1.02B | 1.05B | 1.06B | 1.08B | 1.10B |
| Other Operating Expenses | -- | -- | -- | -- | 0.00 |
| Total Operating Expenses | 7.96B | 7.97B | 7.87B | 7.76B | 7.70B |
| Operating Income | 2.07B | 1.89B | 1.86B | 1.86B | 1.78B |
| Income Before Tax | 520.00M | 281.00M | 189.00M | 167.00M | -49.00M |
| Income Tax Expenses | 199.00M | 233.00M | 270.00M | 239.00M | 168.00M |
| Earnings from Continuing Operations | 321.00 | 48.00 | -81.00 | -72.00 | -217.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.00M | 50.00M | 41.00M | 26.00M | 39.00M |
| Net Income | 362.00M | 98.00M | -40.00M | -46.00M | -178.00M |
| EBIT | 2.07B | 1.89B | 1.86B | 1.86B | 1.78B |
| EBITDA | 3.29B | 3.13B | 3.11B | 3.13B | 3.07B |
| EPS Basic | 0.97 | 0.26 | -0.11 | -0.13 | -0.49 |
| Normalized Basic EPS | 0.96 | 0.81 | 0.95 | 0.85 | 0.71 |
| EPS Diluted | 0.97 | 0.26 | -0.11 | -0.13 | -0.49 |
| Normalized Diluted EPS | 0.96 | 0.81 | 0.95 | 0.85 | 0.71 |
| Average Basic Shares Outstanding | 1.49B | 1.48B | 1.48B | 1.48B | 1.46B |
| Average Diluted Shares Outstanding | 1.49B | 1.48B | 1.48B | 1.48B | 1.46B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |